News Releases

Thursday, February 16, 2017

University Hospitals (UH) Sports Medicine renews partnership with Rite Aid Cleveland Marathon

CLEVELAND – After a successful first year of partnership in 2016, University Hospitals (UH) Sports Medicine will return as the official health care provider for the 40th running of the Rite Aid Cleveland Marathon.
As the official health care partner of the 2017 Rite Aid Cleveland Marathon, UH Sports Medicine physicians will provide on site care for all runners participating in the full, half, 10K, 8K and 5K races that occur during the weekend of May 20-21.
Per the agreement, UH will provide medical counsel and coverage for an estimated 15,000 runners who annually enjoy the course along Lake Erie’s shoreline. Jeffrey Luk, MD, will return as the medical director for the marathon and is excited to help athletes complete the course competitively and safely.

“I’m excited about returning as the medical director for the 2017 Rite Aid Cleveland Marathon,” said Dr. Luk. “We at University Hospitals are looking forward to building on last year’s successful race and to again provide medical staffing for the marathon. Our plan is to ensure a fun and most importantly, a safe marathon for all participants.”

Monday, February 13, 2017

High rates of satisfaction for applicator free local estrogen Softgel Ovule in post-menopausal women

CLEVELAND — A new investigational delivery method for localized vaginal estrogen therapy that utilizes an applicator free softgel to alleviate moderate-to-severe vaginal pain during intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), received high rates of patient satisfaction among post-menopausal women, according to post-trial survey results published in the journal Menopause.
“These survey results show that something as simple as a change to a more elegant delivery system that is easier to use and not messy might empower more post-menopausal women to seek prescription treatment for VVA, and perhaps help them stay with the application guidelines for longer,” said study first author Sheryl Kingsberg, PhD, Division Chief, OB/GYN Behavioral Medicine, UH Cleveland Medical Center; Professor of Obstetrics and Gynecology and Psychiatry, Case Western Reserve University School of Medicine; and first author of the survey analysis. “We still have to find better ways to educate the millions of women suffering with VVA about the symptoms, however, so that more of them know it is common, decide to discuss treatment with their healthcare professional, and seek symptom relief with appropriate treatment.”
The new results were part of a multi-center randomized, placebo-controlled phase 3 clinical trial for TX004HR, an investigational bio-identical 17β-estradiol applicator free vaginal softgel capsule. Previous publications have shown TX004HR to be safe and effective at alleviating symptoms of VVA. The survey, which included 731 respondents with a 96 percent response rate, sought to quantify participants’ satisfaction with the application method and overall treatment delivery system. The majority of women taking either TX004HR or placebo (85.4 – 92.1 percent) found the product easy to use.

Thursday, February 09, 2017

Harrington Discovery Institute at University Hospitals opens call for 2018 Harrington Scholar-Innovator Award

CLEVELAND – Harrington Discovery Institute at University Hospitals (UH) in Cleveland, Ohio – part of The Harrington Project for Discovery & Development – has opened its annual award competition to fund physician-scientist innovators at major academic medical centers across the country to advance their work toward therapeutic discoveries. This effort is funded with support from University Hospitals and impact philanthropist Ron Harrington and his family, for whom the institute and overarching project are named.  
The Harrington Discovery Institute holds an annual competition to identify the nation’s most talented physician-scientists, who will be supported financially and professionally, all to help bridge the gap between breakthrough discovery and promising drugs that can be readied for clinical development.   
Applicants have the opportunity to receive:
  • $100,000 guaranteed; opportunity to quality for up to $700,000
  • Drug development and project management support through Harrington Discovery
Institute’s Innovation Support Center
Letters of Intent are being accepted thourgh April 5, 2017
All applications must be submitted on line at

Wednesday, February 08, 2017

Northern Ohio Trauma System (NOTS) expands network

CLEVELAND – Cleveland Clinic, MetroHealth and University Hospitals have joined together to create a new Northern Ohio Trauma System (NOTS), which will provide coordinated trauma care to patients throughout Cuyahoga County and the seven-county Northeast Ohio region.
As part of this enhanced trauma network, University Hospitals is adding its trauma expertise to NOTS. The NOTS network was originally formed in 2010 between MetroHealth and Cleveland Clinic, and NOTS assisted the City of Cleveland public safety forces to get the right patient to the right place at the right time for their care.
Building on the collaboration among Cleveland Clinic, MetroHealth and University Hospitals during recent public health events including Flu and Ebola responses and the Republican National Convention preparation, the three health systems with the full support of Cleveland Mayor, Frank G. Jackson, strengthened their work together to enhance trauma service coordination across the region.

Friday, February 03, 2017

University Hospitals appoints Peter U. Bergmann President of UH Parma Medical Center

CLEVELAND – University Hospitals has appointed Peter U. Bergmann, FACHE, as President of UH Parma Medical Center, effective March 6.
A highly experienced health care executive, Bergmann has served as President and CEO of Sisters of Charity Hospital in Buffalo, N.Y., since 2006. His strategies and leadership at the two-campus Catholic teaching hospital have improved efficiency, enhanced patient safety and generated strong financial results.
“Peter’s collaborative leadership style and relationship-building successes will benefit our patients as we continue to expand and align UH’s Westside service offerings,” said Richard A. Hanson, President, UH Community Hospitals and Ambulatory Network. “He and his team will advance the hospital’s role as a valued resource for Westside communities with a focus on physician recruitment, quality of care, patient experience, and employee and physician engagement.”

You must be logged in to view this item.


This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.